A recent study by scientists from Japanese
universities has shown that the shape of cell-derived
nanoparticles, known as “extracellular vesicles” (EVs), in body
fluids could be a biomarker for identifying types of cancer. In the
study, the scientists successfully measured the shape distributions
of EVs derived from liver, breast, and colorectal cancer cells,
showing that the shape distributions differ from one another. The
findings were recently published in the journal Analytical
Chemistry.
